SCHEMBL8278302

SCHEMBL8278302

O=S(=O)(Nc1ccc2cc[nH]c2c1)c1ccc(O)cc1O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 7/20 0.55
CYP19A1 P11511 1/20 0.55
HTR6 P50406 1/20 0.55
HSP90AA1 P07900 3/20 0.53
HSP90AB1 P08238 3/20 0.53
TYR P14679 1/20 0.51
IDH1 O75874 1/20 0.47
GAA P10253 3/20 0.43
ALDH1A1 P00352 2/20 0.43
GFER P55789 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
HDAC3 O15379 1/20 0.42
HDAC4 P56524 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC7 Q8WUI4 1/20 0.42
HDAC2 Q92769 1/20 0.42
HDAC10 Q969S8 1/20 0.42
HDAC11 Q96DB2 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16719591 0.79 ESR1 (0.62) ESR1CYP19A1HTR6TYRIDH1
SCHEMBL4884802 0.76 ESR1 (0.70) ESR1CYP19A1HTR6HDAC1HDAC8
SCHEMBL16719331 0.76 ESR1 (0.78) ESR1CYP19A1HTR6IDH1ALDH1A1
SCHEMBL19329420 0.74 ESR1 (0.53) ESR1CYP19A1HTR6IDH1ALDH1A1
SCHEMBL16719422 0.74 ESR1 (0.59) ESR1CYP19A1HTR6TYRIDH1
SCHEMBL5820194 0.73 ESR1 (0.74) ESR1CYP19A1HTR6GAAALDH1A1
Sulfuric Acid SCHEMBL23541029 0.73 TYR (0.81) ESR1CYP19A1HTR6TYRGAA
Sulfuric Acid SCHEMBL29374819 0.73 TYR (0.81) ESR1CYP19A1HTR6TYRGAA
SCHEMBL31701332 0.73 ESR1 (0.61) ESR1CYP19A1HTR6IDH1ALDH1A1
SCHEMBL1607103 0.72 PIP4K2A (0.64) ESR1CYP19A1HTR6HDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005090298-A1 SULPHONAMIDE DERIVATIVES BIOTIE THERAPIES CORPORATION (FI) 2005-09-29 WO disclosed